Evolution of metabolic disorders after resection of pheochromocytomas and paragangliomas: a single-center study
Med Pharm Rep. 2025 Apr;98(2):190-195. doi: 10.15386/mpr-2741. Epub 2025 Apr 29.ABSTRACTBACKGROUND AND AIMS: Pheochromocytomas and paragangliomas are rare neuroendocrine tumors, responsible for inappropriate secretion of catecholamines, inducing metabolic disorders, increasing basal metabolic rate.